Barchart.com
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)
182.00 x 1 184.91 x 1
Post-market by (Cboe BZX)
180.37 +3.32 (+1.88%) 04/24/25 [NYSE]
182.00 x 1 184.91 x 1
Post-market 182.50 +2.13 (+1.18%) 19:58 ET
News & Headlines for Thu, Apr 24th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
ABBV
AbbVie (ABBV) Reports Earnings Tomorrow: What To Expect StockStory - Thu Apr 24, 2:01AM CDT

AbbVie (ABBV) Reports Earnings Tomorrow: What To Expect

ABBV : 180.37 (+1.88%)
2 High-Yield Dividend Stocks to Buy for Passive Income Motley Fool - Wed Apr 23, 7:30AM CDT

Passive income is essential in retirement, but building a dependable stream isn't easy. Fortunately, top-tier dividend stocks can do the heavy lifting. The key is focusing on companies with strong yields,...

ABBV : 180.37 (+1.88%)
PFE : 22.78 (+1.74%)
Down day candlestick chart by Bigc Studio via Shutterstock
Stocks Set to Open Sharply Lower After Trump’s Push Against Powell, U.S. Economic Data and Tech Earnings in Focus Barchart - Mon Apr 21, 4:46AM CDT

June S&P 500 E-Mini futures (ESM25) are down -1.09%, and June Nasdaq 100 E-Mini futures (NQM25) are down -1.23% this morning, pointing to a sharply lower open on Wall Street as U.S. President Donald Trump’s...

GOOGL : 159.28 (+2.53%)
AVGO : 188.15 (+6.35%)
VZ : 42.81 (+0.26%)
MRK : 79.84 (+1.40%)
TXN : 162.13 (+6.56%)
UNH : 424.25 (-0.87%)
ESM25 : 5,528.50 (+0.31%)
TSLA : 259.51 (+3.50%)
T : 27.53 (+1.25%)
IBM : 229.33 (-6.58%)
LLY : 859.73 (+3.65%)
NQM25 : 19,407.75 (+0.44%)
Is AbbVie Stock a Buy? Motley Fool - Sun Apr 20, 7:15AM CDT

The pharmaceutical giant has been a roller coaster over the past several months.

AGN.AX : 0.675 (+5.47%)
ABBV : 180.37 (+1.88%)
Housing Figures in Picture for Next Week Baystreet - Thu Apr 17, 3:18PM CDT

U.S. Monday Economic Lookahead U.S. leading economic indicators (March) Featured Earnings ...

MEDP : 302.88 (+4.25%)
AON : 365.05 (-1.02%)
GOOGL : 159.28 (+2.53%)
AGNC : 8.72 (+1.28%)
WRB : 71.75 (+0.72%)
HCA : 341.41 (+1.62%)
NVS : 111.17 (+0.94%)
ABBV : 180.37 (+1.88%)
TMUS : 262.18 (+1.09%)
TSLA : 259.51 (+3.50%)
T : 27.53 (+1.25%)
IBM : 229.33 (-6.58%)
ABBV
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks StockStory - Wed Apr 16, 4:06AM CDT

Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks

SRPT : 61.76 (+3.82%)
BMRN : 62.74 (+1.29%)
ABBV : 180.37 (+1.88%)
MRNA : 27.39 (+3.20%)
AMGN : 279.84 (+0.70%)
Top Research Reports for AbbVie, TJX & Charles Schwab
Top Research Reports for AbbVie, TJX & Charles Schwab Zacks Investment Research - Tue Apr 15, 4:36PM CDT

Tuesday, April 15, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV),...

TJX : 126.50 (+0.80%)
ENB : 46.36 (+1.64%)
SCHW : 79.38 (+1.97%)
ABBV : 180.37 (+1.88%)
HSBC : 55.70 (-0.55%)
GE : 197.41 (+1.93%)
The Zacks Analyst Blog Merck and AbbVie
The Zacks Analyst Blog Merck and AbbVie Zacks Investment Research - Tue Apr 15, 7:04AM CDT

For Immediate ReleasesChicago, IL – April 15, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

MRK : 79.84 (+1.40%)
ABBV : 180.37 (+1.88%)
ABBV vs. MRK: Which Drug Giant is a Better Buy Now?
ABBV vs. MRK: Which Drug Giant is a Better Buy Now? Zacks Investment Research - Mon Apr 14, 10:48AM CDT

Merck MRK and AbbVie ABBV are leading pharmaceutical companies with strong portfolios in oncology and immunology. While AbbVie also markets products for aesthetics, neuroscience and eye care, Merck has...

NVO : 62.63 (+2.17%)
MRK : 79.84 (+1.40%)
LLY : 859.73 (+3.65%)
ABBV : 180.37 (+1.88%)
Abbvie Inc logo and stock chart-by IgorGolovniov via Shutterstock
Earnings Preview: What to Expect From AbbVie's Report Barchart - Mon Apr 14, 4:31AM CDT

AbbVie is scheduled to report its first-quarter results this month, with analysts anticipating a modest growth in earnings.

XLV : 137.39 (+1.22%)
$SPX : 5,484.77 (+2.03%)
ABBV : 180.37 (+1.88%)

Barchart Exclusives

1 ‘Strong Buy’ Dividend Stock to Buy for an ‘America First’ World Barchart - 49 minutes ago
GE Aerospace is emerging as a top “Strong Buy” dividend stock, with an 11% jump in revenue and a nearly $1 billion investment in U.S. manufacturing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot